Abstract
The incidence of cystic fibrosis (CF) in Finland, 1∶25 000 newborn, is one of the lowest in Caucasian populations. The ΔF508 mutation accounts for 18/40 (45%) of CF chromosomes in Finland. Other mutations were therefore sought among the remaining 55%. Twelve out of 40 chromosomes (30%) were found to carry 394delTT, whereas G542X and 3732delA were each detected in one chromosome. Eight mutations remained unidentified using a testing panel for 26 mutations. Mutation 394delTT was associated exclusively with haplotype 23-36-13. Five unknown mutations were associated with different haplotypes for microsatellite markers, whereas three shared the same haplotype. Most ΔF508 mutations and all unidentified mutations originated from regions of old and dense settlement in the coastal regions, whereas 394delTT was geographically clustered and enriched in a rural location, consistent with a local founder effect. The remote location of Finland and her population history give a plausible explanation for the rarity of CF in Finland.
Similar content being viewed by others
References
Casals T, Vázguez C, Lázaro C, Girbau E, Giménez FJ, Estivill X (1992) Cystic fibrosis in the Basque country: high frequency of mutation ΔF508 in patients of Basque origin. Am J Hum Genet 339:119–120
Casals T, Nunes V, Palacio A, Giménez J, Gaona A, Ibá~nez N, Morral N, Estivill X (1993) Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area. Hum Genet 91:66–70
Cavalli-Sforza LL, Piazza A (1993) Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet 1:3–18
European Working Group for Cystic Fibrosis Genetics (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 85:436–445
Gasparini P, Bonizzatto A, Dognini M, Pignatti PF (1992) Restriction site generating polymerase chain reaction (RG-PCR) for the detection of hidden genetic variation: application to the study of some common CF mutations. Mol Cell Probes 6:1–7
Kere J, Norio R, Savilahti E, Estivill X, Chapelle A de la (1989) Cystic fibrosis in Finland: a molecular and genealogical study. Hum Genet 83:20–25
Kere J, Norio R, Savilahti E, Estivill X, Chapelle A de la (1990) Cystic fibrosis mutation ΔF508 in Finland: other mutations predominate. Hum Genet 85:413–415
Morral N, Estivill X (1992) Multiplex PCR amplification of three microsatellites within the CFTR gene. Genomics 13:1362–1364
Morral N, Nunes V, Casals T, Chillon M, Giménez J, Bertranpetit J, Estivll X (1993) Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. Hum Mol Genet (in press)
Nevanlinna HR (1972) The Finnish population structure. A genetic and genealogical study. Hereditas 71:195–236
Norio R (1981) Diseases of Finland and Scandinavia. In: Rothschild H (ed) Biocultural aspects of disease. Academic Press, New York, pp 359–415
Norio R, Nevanlinna HR, Perheentupa J (1973) Hereditary diseases in Finland: rare flora in rare soil. Ann Clin Res 5:109–141
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using polymerase chain reaction. Genomics 5:874–879
Schwartz M, Anvret M, Claustres M, Eiken HG, Eiklid K, Schaedel C, Stolpe L, Tjaenebjaerg L (1994) 394delTT: a Nordic cystic fibrosis mutation. Hum Genet 93:157–161
Tsui L-C (1992) Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the cystic fibrosis genetic analysis consortium. Hum Mutat 1:197–203
Zielensky J, Rozmahel R, Bozon D, Kerem B-S, Grzelczack Z, Riordan JR, Rommens J, Tsui L-C (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10:214–228
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kere, J., Estivill, X., Chillón, M. et al. Cystic fibrosis in a low-incidence population: two major mutations in Finland. Hum Genet 93, 162–166 (1994). https://doi.org/10.1007/BF00210603
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00210603